Oncogenic and tumor-suppressive forces converge on a progenitor niche at the benign-to-malignant transition
Preprint
Abstract
The transition from benign to malignant growth is a pivotal yet poorly understood step in cancer progression that marks the shift from a pathologically inert condition to a clinically lethal disease. Here, we integrate lineage tracing, single-cell and spatial transcriptomics to visualize the molecular, cellular and tissue-level events that promote or restrain malignancy during the tumor initiation in mouse models of pancreatic ductal adenocarcinoma (PDAC). We identify a discrete progenitor-like population of KRAS-mutant cells that co-activates oncogenic and tumor-suppressive programs—including p53, CDKN2A, and SMAD4—engaging senescence-like responses and remodeling their microenvironment, ultimately assembling a niche that mirrors invasive PDAC. KRAS inhibition depletes progenitor-like cells and dismantles their niche. Conversely, p53 suppression enables progenitor cell expansion, epithelial–mesenchymal reprogramming, and immune-privileged niche formation. These findings position the progenitor-like state as the convergence point of cancer-driving mutations, plasticity, and tissue remodeling—revealing a critical window for intercepting malignancy at its origin.Keywords
All Related Versions
- Published version: Cell, 189 (10), 2875.
Funding Information
- The Center for Experimental Immuno-Oncology Scholars Program, MSKCC
- Rackham International Student Fellowship, University of Michigan
- Geoffrey Beene Cancer Research Center Grant, MSKCC
- Instituto Ramón y Cajal de Investigación Sanitaria (RYC2023-045857- I)
- AECC 2022 Excellence Program (EPAEC222649IRB)
- Spanish National Research Agency (PID2024-159806OB-I00)
- Spanish National Research Agency (TRANSCAN2022-784-028)
- Spanish National Research Agency (TRNSC235656ALON project)
- Cycle for Survival
- European Research Council (ERC Consolidator Grant IGNITE (Grant Agreement: 101171929))
This publication has 159 references indexed in Scilit:
- KRASG12D inhibition reprograms the microenvironment of early and advanced pancreatic cancer to promote FAS-mediated killing by CD8+ T cellsCancer Cell, 2023
- Emergence of a High-Plasticity Cell State during Lung Cancer EvolutionCancer Cell, 2020
- Integrated Genomic Characterization of Pancreatic Ductal AdenocarcinomaCancer Cell, 2017
- Genetic analyses of isolated high‐grade pancreatic intraepithelial neoplasia (HG‐PanIN) reveal paucity of alterations in TP53 and SMAD4The Journal of Pathology, 2017
- Enzymatic Targeting of the Stroma Ablates Physical Barriers to Treatment of Pancreatic Ductal AdenocarcinomaCancer Cell, 2012
- Chronic Pancreatitis Is Essential for Induction of Pancreatic Ductal Adenocarcinoma by K-Ras Oncogenes in Adult MiceCancer Cell, 2007
- Trp53R172H and KrasG12D cooperate to promote chromosomal instability and widely metastatic pancreatic ductal adenocarcinoma in miceCancer Cell, 2005
- Pattern formation by local self-activation and lateral inhibitionBioEssays, 2000
- Alternative reading frames of the INK4a tumor suppressor gene encode two unrelated proteins capable of inducing cell cycle arrestCell, 1995
- Altered cell cycle arrest and gene amplification potential accompany loss of wild-type p53Cell, 1992